Sort
48,018 grants matching “immunotherapy”
Impact of tuberculosis on the development and function of the immune system in SIV-infected infants
$1,225,642Xiaolei Wang · Tulane University Of Louisiana · R01 · FY2023 · HD
Impact of tuberculosis on the development and function of the immune system in SIV-infected infants
$1,225,642Xiaolei Wang · Tulane University Of Louisiana · R01 · FY2021 · HD
Impact of tuberculosis on the development and function of the immune system in SIV-infected infants
$1,225,614Xiaolei Wang · Tulane University Of Louisiana · R01 · FY2020 · HD
A Phase II Controlled Trial of Allogeneic Mesenchymal Stromal Cells for the Treatment of Refractory Lupus (MiSLE)
$1,225,013Gary S. Gilkeson · Medical University Of South Carolina · U01 · FY2024 · AI
Mechanistic investigation of therapies for Down Syndrome Regression Disorder
$1,224,805Joaquin M. Espinosa · University Of Colorado Denver · R33 · FY2025 · HD
Development of botulinum neurotoxin immunotherapy
$1,224,595University Of California San Francisco · U01 · FY2004 · AI
Preclinical Development of a Thermostable Trivalent Filovirus Vaccine
$1,224,098Axel T Lehrer · University Of Hawaii At Manoa · R01 · FY2018 · AI
Discovery and development of lineage-restricted pediatric cancer surfaceome immunotherapeutic targets
$1,223,848John M Maris · Children'S Hosp Of Philadelphia · U54 · FY2018 · CA
REGULATION OF ANTI-TUMOR IMMUNITY
$1,223,793Eckhard R Podack · University Of Miami School Of Medicine · P01 · FY2007 · CA
GENERAL CLINICAL RESEARCH CENTER
$1,223,437University Of Texas Hlth Sci Ctr Houston · M01 · FY2000 · RR
New Jersey Pediatric AIDS Clinical Trials Consortium
$1,223,366Univ Of Med/Dent Of Nj-Nj Medical School · U01 · FY2004 · AI
Novel Molecular Therapies of Prostate Cancer
$1,222,825Dario C. Altieri · Wistar Institute · P01 · FY2018 · CA
IN VIVO 31P MRS STUDIES OF NON-HODGKIN'S LYMPHOMA
$1,222,597Fernando Arias-Mendoza · Columbia University Health Sciences · R01 · FY2010 · CA
Analysis of Host-Pathogen Interactions
$1,222,253Ronald Germain · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Innate inflammatory responses during pulmonary infections
$1,222,241Katrin Mayer-Barber · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
Therapeutic Fully Human Monoclonal Antibodies against Vaccina Virus and Smallpox
$1,221,981Shane P Crotty · La Jolla Institute For Immunology · U01 · FY2010 · AI
Immunologic Correlates of Immunization for Cancer
$1,221,861University Of Washington · U54 · FY2002 · CA
The connection of innate and adaptive anti-cancer immunity
$1,221,774John Greiner · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
A platform for T-cell receptor mimic antibody generation modeled using pHLA-A*11:01 KRAS G12D
$1,221,746Michael P Weiner · Precision Biotools Inc · R44 · FY2025 · GM
Preclinical toxicology and pharmacology evaluation of a newTNFR2 antagonistic monoclonal antibody for CTCL therapy
$1,221,684Kenneth Olivier · Boston Immune Technologies And Therapeutics, Inc. · R44 · FY2023 · CA
TissueReM: Whole-Organism, Real-time Decision-enabled 3D Tissue Imaging and Recovery for Molecular Analysis
$1,221,189Madhusudhana Gargesha · Bioinvision, Inc. · R44 · FY2025 · GM
Rational Approaches to Melanoma Therapy
$1,220,153Jessie Villanueva · Wistar Institute · U54 · FY2024 · CA
Rapid response for pandemics: single cell sequencing and deep learning to predict antibody sequences against an emerging antigen
$1,219,945Animesh Ray · Keck Graduate Inst Of Applied Life Scis · R01 · FY2023 · AI
Development of polymeric synthetic biomaterial IP-001 to potentiate asystemic immunotherapy of hepatocellular carcinoma via thermal ablation
$1,219,852Siu Kit Lam · Immunophotonics, Inc. · R44 · FY2023 · CA
Multi-OMICS identification and validation of mechanisms triggered by Immune interventions aimed at reducing the size of the replication competent Reservoir
$1,219,661Rafick-Pierre Sekaly · Emory University · P01 · FY2024 · AI